pravastatin has been researched along with Libman-Sacks Disease in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ángeles-Garay, U; Carrillo-González, AL; Hernández, C; Jara, L; Medina, G; Olvera-Acevedo, A; Peralta-Amaro, AL; Vera-Lastra, OL | 1 |
| Calderón-Aranda, E; Cruz-Dominguez, MP; Jara, LJ; Medina, G; Méndez-Flores, S; Vera-Lastra, O | 1 |
| Funauchi, M; Hino, S; Ikoma, S; Kinoshita, K; Kishimoto, K; Nagare, Y; Nozaki, Y; Shimazu, H; Sugiyama, M; Yano, T | 1 |
| Castellani, LW; Fogelman, AM; Iikuni, N; La Cava, A; Li, H; Lin, Z; Lusis, AJ; Navab, M; Rullo, OJ; Trejo-Lopez, Y; Tsao, BP; Van Dyck, C; Wang, X; Woo, JM; Woo, KM; Wu, H | 1 |
| Major, A; Mendez-Fernandez, Y | 1 |
| Ahmed, A; Burns, MV; Callahan, GB; Cockerell, C; Le, LQ | 1 |
| Bermas, B; Costenbader, KH; de Pablo, P; Finckh, A; Gall, V; Karlson, EW; Liang, MH; Lynch, M; Schur, PH | 1 |
| Aizer, J; Chibnik, LB; Costenbader, KH; Gall, V; Karlson, EW; Kwon, H; Liang, MH | 1 |
3 trial(s) available for pravastatin and Libman-Sacks Disease
| Article | Year |
|---|---|
[Effect of pravastatine plus ezetimibe on carotid intima media thickness in patients with lupus erythematosus].
Topics: Adult; Anticholesteremic Agents; Atherosclerosis; Carotid Intima-Media Thickness; Drug Administration Schedule; Drug Therapy, Combination; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Longitudinal Studies; Lupus Erythematosus, Systemic; Middle Aged; Pravastatin; Prospective Studies; Treatment Outcome | 2015 |
Barriers to a trial of atherosclerosis prevention in systemic lupus erythematosus.
Topics: Anticholesteremic Agents; Antihypertensive Agents; Arteriosclerosis; Aspirin; Drug Therapy, Combination; Female; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Patient Dropouts; Patient Selection; Pilot Projects; Pravastatin; Ramipril; Treatment Refusal; Vitamin B Complex | 2005 |
A pravastatin dose-escalation study in systemic lupus erythematosus.
Topics: Adult; Body Mass Index; Cholesterol, LDL; Dose-Response Relationship, Drug; Drug Synergism; Female; Glucocorticoids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lupus Erythematosus, Systemic; Middle Aged; Pravastatin | 2007 |
5 other study(ies) available for pravastatin and Libman-Sacks Disease
| Article | Year |
|---|---|
Effect of ezetimibe plus pravastatin on endothelial dysfunction in patients with systemic lupus erythematosus.
Topics: Adult; Anticholesteremic Agents; Atherosclerosis; Brachial Artery; C-Reactive Protein; Cholesterol; Drug Therapy, Combination; Endothelium, Vascular; Ezetimibe; Female; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Pravastatin; Ultrasonography; Vasodilation | 2016 |
Effect of combining ACE inhibitor and statin in lupus-prone mice.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antibodies, Antinuclear; Blood Pressure; Cytokines; Drug Therapy, Combination; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imidazolidines; Immunoglobulin G; Kidney; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Mice, Inbred C3H; Mice, Inbred MRL lpr; Pravastatin; Proteinuria; Random Allocation; Specific Pathogen-Free Organisms | 2010 |
Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis.
Topics: Animals; Apolipoprotein A-I; Apolipoproteins E; Bone Density; Chemokines; Cytokines; Disease Models, Animal; fas Receptor; Female; Immunoglobulin G; Lipids; Lupus Erythematosus, Systemic; Mice; Mice, Inbred C57BL; Mice, Knockout; Peptides; Plaque, Atherosclerotic; Pravastatin | 2010 |
Sizing up stability: combination therapy with Apo-AI peptide mimetics and statins in systemic lupus erythematosus-mediated atherosclerosis.
Topics: Animals; Anticholesteremic Agents; Apolipoprotein A-I; Atherosclerosis; Drug Therapy, Combination; Humans; Lupus Erythematosus, Systemic; Mice; Peptides; Plaque, Atherosclerotic; Pravastatin | 2010 |
Treatment of indeterminate cell histiocytosis with pravastatin.
Topics: Adult; Antigens, CD; Axilla; Comorbidity; Female; Histiocytosis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Lupus Erythematosus, Systemic; Pravastatin | 2011 |